PTC Therapeutics, Inc. Goodwill, Period Increase (Decrease)
PTC Therapeutics, Inc. (PTCT) reported Goodwill, Period Increase (Decrease) of $0 for the 34-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillPeriodIncreaseDecrease · last filed 2026-07-30
- PTC Therapeutics, Inc. goodwill, period increase (decrease) for the quarter ending 2021-09-30 was $0.00.
- PTC Therapeutics, Inc. goodwill, period increase (decrease) for the quarter ending 2021-06-30 was $0.00.
- PTC Therapeutics, Inc. goodwill, period increase (decrease) for the quarter ending 2021-03-31 was $0.00.
- PTC Therapeutics, Inc. goodwill, period increase (decrease) for the quarter ending 2020-09-30 was $0.00.
| Period end | Goodwill, Period Increase (Decrease) 3 month | Goodwill, Period Increase (Decrease) 6 month | Goodwill, Period Increase (Decrease) 9 month | Goodwill, Period Increase (Decrease) 34 month | Goodwill, Period Increase (Decrease) 43 month | Goodwill, Period Increase (Decrease) 46 month | Goodwill, Period Increase (Decrease) 49 month | Goodwill, Period Increase (Decrease) 55 month | Goodwill, Period Increase (Decrease) 58 month | Goodwill, Period Increase (Decrease) 61 month | Goodwill, Period Increase (Decrease) 67 month | Goodwill, Period Increase (Decrease) 70 month | Goodwill, Period Increase (Decrease) 73 month | Goodwill, Period Increase (Decrease) 79 month | Goodwill, Period Increase (Decrease) 82 month | Goodwill, Period Increase (Decrease) 85 month | Goodwill, Period Increase (Decrease) 91 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-30 | ||||||||||||||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | ||||||||||||||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 | ||||||||||||||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | ||||||||||||||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | ||||||||||||||||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | ||||||||||||||||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | ||||||||||||||||
| 2024-03-31 | $0.00 10-Q · filed 2024-04-25 | ||||||||||||||||
| 2023-09-30 | $0.00 10-Q · filed 2023-10-26 | ||||||||||||||||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 | ||||||||||||||||
| 2023-03-31 | $0.00 10-Q · filed 2023-04-27 | ||||||||||||||||
| 2022-09-30 | $0.00 10-Q · filed 2022-10-27 | ||||||||||||||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | ||||||||||||||||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-03 | ||||||||||||||||
| 2021-09-30 | $0.00 10-Q · filed 2021-10-28 | $0.00 derived: sum of 2 quarters · filed 2021-10-28 | $0.00 10-Q · filed 2021-10-28 | ||||||||||||||
| 2021-06-30 | $0.00 10-Q · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | |||||||||||||||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-04 | ||||||||||||||||
| 2020-09-30 | $0.00 10-Q · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |